+
Site Tour
STROKE RISK FACTORS

Atrial fibrillation (AF) is associated with a 5-fold increase in the risk of ischemic stroke.1 Left atrial appendage (LAA) closure reduces the risk of stroke in non-valvular AF (NVAF) patients who are seeking an alternative to oral anticoagulants.2,3

2016 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPED IN COLLABORATION WITH THE EUROPEAN ASSOCIATION OF CARDIOTHORACIC SURGERY (EACTS)¹

ACCESS TO ALL TREATMENT OPTIONS FOR AF

Structured support for lifestyle changes

Anticoagulation

Rate control


CATHETER AND SURGICAL INTERVENTIONS (ABLATION, LAA OCCLUDER, AF SURGERY, ETC.)

Antiarrhythmic drugs

Complex management decisions underpinned by an AF Heart Team


RECOMMENDATION


CLASS


LEVEL

After surgical occlusion or exclusion of the LAA, it is
recommended to continue anticoagulation in at-risk patients with AF for stroke prevention
IB
LAA occlusion may be considered for stroke prevention in patients with AF and contraindications for long-term oral anticoagulation treatment (e.g. those with a previous life- threatening bleed without reversible cause)IIbB
Surgical occlusion or exclusion of the LAA may be
considered for stroke prevention in patients with AF
undergoing open cardiac surgery.
IIbB
Surgical occlusion or exclusion of the LAA may be
considered for stroke prevention in patients with AF
undergoing thoracoscopic AF surgery
IIbB

PROFESSOR HANS-CHRISTOPH DIENER

Prevention of stroke in patients with AF:

To learn more about the proof of concept studies that led to the current class IIb recommendation for LAAO in the management of AF, please click on the publication link below:

Publication

Connext
Live

Hear from the most respected KOLs in cardiovascular and stroke prevention, collaborate on best practice and be part of the CONNEXT community.

Find out more

 

 

TV


HUB

References
  1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–2962. doi.org/10.1093/eurheartj/ehw210.
  2. Diener H-C, Landmesser U. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Future Neurol. 2020;15(3). doi.org/10.2217/fnl-2020-0001.

© Abbott 2024. All rights reserved. 9-EH-5-14477-01 04-2024 REV A

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline